{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:13:22Z","timestamp":1791213202905,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T00:00:00Z","timestamp":1210291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1245\/s10434-008-9915-0","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T14:08:34Z","timestamp":1210255714000},"page":"2034-2041","source":"Crossref","is-referenced-by-count":40,"title":["A Single-Institution Validation of the AJCC Staging System for Stage IV Melanoma"],"prefix":"10.1245","volume":"15","author":[{"given":"Heather B.","family":"Neuman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ishill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Sue","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan C.","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Coit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,9]]},"reference":[{"key":"9915_CR1","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ, et\u00a0al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635\u201348","journal-title":"J Clin Oncol"},{"key":"9915_CR2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/1097-0142(20010315)91:6<1148::AID-CNCR1111>3.0.CO;2-#","volume":"91","author":"JM Unger","year":"2001","unstructured":"Unger JM, Flaherty LE, Liu PY, et\u00a0al. Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials. Cancer 2001; 91:1148\u201355","journal-title":"Cancer"},{"key":"9915_CR3","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0959-8049(02)00123-5","volume":"38","author":"U Keilholz","year":"2002","unstructured":"Keilholz U, Martus P, Punt CJ, et\u00a0al. Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatin. Eur J Cancer 2002; 38:1501\u201311","journal-title":"Eur J Cancer"},{"key":"9915_CR4","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1200\/JCO.2000.18.22.3782","volume":"18","author":"J Manola","year":"2000","unstructured":"Manola J, Atkins M, Ibrahim J, et\u00a0al. Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol 2000; 18:3782\u201393","journal-title":"J Clin Oncol"},{"key":"9915_CR5","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.1998.16.9.2921","volume":"16","author":"U Keilholz","year":"1998","unstructured":"Keilholz U, Conradt C, Legha SS, et\u00a0al. Results of interleukin-2\u2013based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol 1998; 16:2921\u20139","journal-title":"J Clin Oncol"},{"key":"9915_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000011836","volume":"55","author":"CI Falkson","year":"1998","unstructured":"Falkson CI, Falkson HC Prognostic factors in metastatic malignant melanoma. An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972\u20131992. Oncology 1998; 55:59\u201364","journal-title":"Oncology"},{"key":"9915_CR7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.1998.16.3.1103","volume":"16","author":"O Eton","year":"1998","unstructured":"Eton O, Legha SS, Moon TE, et\u00a0al. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol 1998; 16:1103\u201311","journal-title":"J Clin Oncol"},{"key":"9915_CR8","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2345::AID-CNCR8>3.0.CO;2-K","volume":"79","author":"CU Brand","year":"1997","unstructured":"Brand CU, Ellwanger U, Stroebel W, et\u00a0al. Prolonged survival of 2\u00a0years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer 1997; 79:2345\u201353","journal-title":"Cancer"},{"key":"9915_CR9","first-page":"193","volume":"181","author":"A Barth","year":"1995","unstructured":"Barth A, Wanek LA, Morton DL Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995; 181:193\u2013201","journal-title":"J Am Coll Surg"},{"key":"9915_CR10","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/1097-0142(19931115)72:10<3091::AID-CNCR2820721034>3.0.CO;2-V","volume":"72","author":"MN Sirott","year":"1993","unstructured":"Sirott MN, Bajorin DF, Wong GY, et\u00a0al. Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer 1993; 72:3091\u20138","journal-title":"Cancer"},{"key":"9915_CR11","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/1097-0142(19930515)71:10<2995::AID-CNCR2820711018>3.0.CO;2-P","volume":"71","author":"L Ryan","year":"1993","unstructured":"Ryan L, Kramar A, Borden E Prognostic factors in metastatic melanoma. Cancer 1993; 71:2995\u20133005","journal-title":"Cancer"},{"key":"9915_CR12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.1983.1.2.126","volume":"1","author":"CM Balch","year":"1983","unstructured":"Balch CM, Soong SJ, Murad TM, et\u00a0al. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983; 1:126\u201334","journal-title":"J Clin Oncol"},{"key":"9915_CR13","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/1097-0142(19821015)50:8<1656::AID-CNCR2820500833>3.0.CO;2-L","volume":"50","author":"LG Feun","year":"1982","unstructured":"Feun LG, Gutterman J, Burgess MA, et\u00a0al. The natural history of resectable metastatic melanoma (stage IVA melanoma). Cancer 1982; 50:1656\u201363","journal-title":"Cancer"},{"key":"9915_CR14","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/1097-0142(19820515)49:10<2192::AID-CNCR2820491035>3.0.CO;2-R","volume":"49","author":"CA Presant","year":"1982","unstructured":"Presant CA, Bartolucci AA Prognostic factors in metastatic malignant melanoma: the Southeastern Cancer Study Group experience. Cancer 1982; 49:2192\u20136","journal-title":"Cancer"},{"key":"9915_CR15","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE, et\u00a0al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19:3622\u201334","journal-title":"J Clin Oncol"},{"key":"9915_CR16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archsurg.139.9.961","volume":"139","author":"R Essner","year":"2004","unstructured":"Essner R, Lee JH, Wanek LA, et\u00a0al. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 2004; 139:961\u20136, discussion 966-7","journal-title":"Arch Surg"},{"key":"9915_CR17","first-page":"295","volume":"115","author":"CP Karakousis","year":"1994","unstructured":"Karakousis CP, Velez A, Driscoll DL, et\u00a0al. Metastasectomy in malignant melanoma. Surgery 1994; 115:295\u2013302","journal-title":"Surgery"},{"key":"9915_CR18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jtcvs.2006.08.065","volume":"133","author":"RP Petersen","year":"2007","unstructured":"Petersen RP, Hanish SI, Haney JC, et\u00a0al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 2007; 133:104\u201310","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9915_CR19","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1245\/s10434-007-9448-y","volume":"14","author":"HB Neuman","year":"2007","unstructured":"Neuman HB, Patel A, Hanlon C, et\u00a0al. Stage IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol 2007; 14:2847\u201353","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-008-9915-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-008-9915-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-008-9915-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:31:28Z","timestamp":1572971488000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-008-9915-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,9]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["9915"],"URL":"https:\/\/doi.org\/10.1245\/s10434-008-9915-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,9]]}}}